Introduction
Viral infection, drugs, or autoimmune hepatitis are the primary causes of acute liver injury (ALI). Malignant infiltration is a relatively uncommon etiology and is usually secondary to lymphoma or leukemia [1, 2] . Hepatic metastases of solid tumors usually have a chronic presentation instead of an acute deterioration of hepatic function, and they rarely cause ALI. Therefore, severe ALI in patients receiving chemotherapy is most likely due to either drugs or acute viral hepatitis. We report the case of a patient with colon cancer who presented with ALI caused by lymphangitic liver metastasis. A 56-year-old man was diagnosed with cancer of the ascending colon along with retroperitoneal lymph node and peritoneal metastases. After six cycles of palliative chemotherapy, he presented with acute-onset jaundice. Imaging examinations did not show abnormal liver findings other than a periportal linear hypoattenuating area, and endoscopic retrograde cholangiography revealed a tight stricture of the proximal common bile duct. Total bilirubin continued to increase after endoscopic sphincterotomy and biliary stent insertion. Blind liver biopsy revealed tumor infiltration along liver lymphatics, but ruled out tumor involvement of hepatic parenchyma and sinusoids. Tumor cells were predominantly confined to within the lymphatic vessels and were not observed in the arteries or veins. Although one loading dose of cetuximab and two fractions of palliative radiotherapy were administered, the patient succumbed to acute liver injury 30 days after the development of jaundice. (Fig. 1) . Endoscopic retrograde cholangiography on hospital day 2 showed a tight stricture of the proximal common bile duct. Endoscopic sphincterotomy and biliary stenting into the common bile duct was performed. However, the total bilirubin level continued to increase even after sphincterotomy and rose to 16.7 mg/dL on hospital day Immunohistochemical staining (×200) shows intense membranous expression of CK20 (B). Tumor cells are confined within lymphatic vessels, which express D2-40 (×400), a lymphatic epithelial marker (C).
Abdominal ultrasonography did not show biliary duct dilata-
tion but showed an increase in ascites. Blind liver biopsy was performed on hospital day 10 because a hepatic parenchymal pathological process, rather than biliary tract obstruction, was suspected.
The biopsy specimen revealed tumor infiltration along the liver lymphatics ( Fig. 2A) . artery, and bile duct obstruction [5, 6] . In our case, blind liver biopsy showed that tumor cells were confined within lymphatic vessels in the interstitium, not sinusoidal spaces, and the hepatic parenchyma was free of tumor involvement. These findings are consistent with lymphangitic liver metastasis. To our knowledge, this is the first reported case of lymphangitic spread of colon cancer to the liver. Differential diagnosis of acute hepatic injury without significant radiological morphological changes in liver includes hepatitis, fatty infiltration, glycogen storage disease, amyloidosis, passive congestion, and diffuse lymphangitic metastasis, as in this case. Lymphangitic liver metastasis is hard to diagnose radiologically. On CT, the slender and irregularly shaped areas of low attenuation around portal branches, i.e., the "periportal collar,"
can be observed; these findings were noted in this case as well (Fig. 1) . This finding correlates with dilated lymphatics, and is considered a characteristic finding of lymphangitic metastasis to the liver [7] . However, these radiological characteristics are typical not only of lymphangitic metastases but also of hepatic lymphedema because of cirrhosis or congestive heart failure.
On magnetic resonance imaging (MRI), lymphangitic metastasis is associated with a prominent geographic signal drop on T2-weighted imaging after the administration of superparamagnetic iron oxide [8] . However, deterioration of our patient's condition prevented further workup with MRI.
We conclude that diffuse lymphangitic liver metastasis might be considered with other differential diagnoses in patients with a history of colorectal cancer presenting with progressive jaundice without biliary tract dilatation or other clinically consistent morphological changes. In such patients, radiological findings are rarely specific for the diagnosis of lymphangitic metastasis, and blind liver biopsy should be considered in highly suspicious cases.
